Randomized clinical trial of continuous sutures or non-penetrating clips for radiocephalic arteriovenous fistula

The British Journal of Surgery
C J ZeebregtsR van Schilfgaarde

Abstract

Despite several modifications to the original design, patency rates of radiocephalic arteriovenous fistulas have changed little since the first report in 1966. The use of non-penetrating clips for vascular anastomosis on the outcome of such fistulas was studied. Between January 2000 and August 2003, 107 primary radiocephalic fistulas were constructed in 98 patients. The vascular anastomoses were performed at random with either sutures (n = 56) or clips (n = 51). Although there were trends for better primary and primary assisted patency of clipped fistulas, the differences were not statistically significant. The 6-month primary patency rate was 61 per cent with sutures and 69 per cent with clips (P = 0.393). The mean(s.d.) primary patency was 315(306) and 285(285) days for clipped and sutured fistulas respectively. With regard to secondary patency, clipped fistulas were better (P = 0.009). The mean(s.d.) secondary patency was 435(376) and 344(316) days for clipped and sutured fistulas, respectively. There were no significant differences in flow characteristics, number of revisions or other morbidity. This randomized clinical trial provided further evidence that the use of vascular clips may improve the patency rate of radiocepha...Continue Reading

References

Nov 17, 1966·The New England Journal of Medicine·M J BresciaB J Hurwich
Jul 1, 1997·Journal of Vascular Surgery·A LeppäniemiN Rich
Oct 8, 1999·Journal of Vascular Surgery·P G KalmanK W Sniderman
Mar 15, 2001·American Journal of Surgery·J W CookP Heinl
May 16, 2001·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·K KomoriK Sugimachi
Oct 23, 2001·Vascular Surgery·G StansbyT Schmitz-Rixen
Mar 6, 2002·Journal of Vascular Surgery·Anton N SidawyK Craig Kent
May 23, 2002·The European Journal of Surgery = Acta Chirurgica·Clark ZeebregtsReinout van Schilfgaarde
Dec 18, 2002·ANZ Journal of Surgery·Wayne J HawthorneJohn P Fletcher
Jun 12, 2004·American Journal of Surgery·Clark J ZeebregtsReinout van Schilfgaarde

❮ Previous
Next ❯

Citations

Nov 5, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ahmed A Al-JaishiLouise M Moist
Jul 31, 2012·Annals of Vascular Surgery·Jeroen M W DonkerLijckle van der Laan
Feb 3, 2012·Annals of Vascular Surgery·Patrick A StoneAli F AbuRahma
May 14, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·C J ZeebregtsJ J A M van den Dungen
Dec 21, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S K Kakkos, I A Tsolakis
Sep 30, 2010·Journal of Vascular Surgery·Michalis ArgiriouChristos Charitos
Nov 9, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P P G M RooijensT I Yo
May 17, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·C J Zeebregts
Aug 21, 2012·ANZ Journal of Surgery·Stuart Robert Walker
Jun 14, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maurizio GallieniEvi Nagler
Aug 12, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Charmaine E LokUNKNOWN National Kidney Foundation

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.